281 related articles for article (PubMed ID: 16958528)
1. Diastereoselective synthesis of novel iminosugar-containing UDP-Galf mimics: potential inhibitors of UDP-Gal mutase and UDP-Galf transferases.
Liautard V; Christina AE; Desvergnes V; Martin OR
J Org Chem; 2006 Sep; 71(19):7337-45. PubMed ID: 16958528
[TBL] [Abstract][Full Text] [Related]
2. Convergent and stereoselective synthesis of iminosugar-containing Galf and UDP-Galf mimicks: evaluation as inhibitors of UDP-Gal mutase.
Liautard V; Desvergnes V; Itoh K; Liu HW; Martin OR
J Org Chem; 2008 Apr; 73(8):3103-15. PubMed ID: 18358048
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective synthesis of alpha-C-Substituted 1,4-dideoxy-1,4-imino-D-galactitols. Toward original UDP-Galf mimics via cross-metathesis.
Liautard V; Desvergnes V; Martin OR
Org Lett; 2006 Mar; 8(7):1299-302. PubMed ID: 16562876
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and inhibition properties of conformational probes for the mutase-catalyzed UDP-galactopyranose/furanose interconversion.
Caravano A; Mengin-Lecreulx D; Brondello JM; Vincent SP; Sinaÿ P
Chemistry; 2003 Dec; 9(23):5888-98. PubMed ID: 14673861
[TBL] [Abstract][Full Text] [Related]
5. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
[TBL] [Abstract][Full Text] [Related]
6. Enzymatic synthesis of UDP-galactofuranose and an assay for UDP-galactopyranose mutase based on high-performance liquid chromatography.
Lee R; Monsey D; Weston A; Duncan K; Rithner C; McNeil M
Anal Biochem; 1996 Nov; 242(1):1-7. PubMed ID: 8923956
[TBL] [Abstract][Full Text] [Related]
7. Chemical probes of UDP-galactopyranose mutase.
Carlson EE; May JF; Kiessling LL
Chem Biol; 2006 Aug; 13(8):825-37. PubMed ID: 16931332
[TBL] [Abstract][Full Text] [Related]
8. 1,4-Anhydrogalactopyranose is not an intermediate of the mutase catalyzed UDP-galactopyranose/furanose interconversion.
Caravano A; Sinaÿ P; Vincent SP
Bioorg Med Chem Lett; 2006 Mar; 16(5):1123-5. PubMed ID: 16377186
[TBL] [Abstract][Full Text] [Related]
9. Synthetic UDP-furanoses as potent inhibitors of mycobacterial galactan biogenesis.
Peltier P; Beláňová M; Dianišková P; Zhou R; Zheng RB; Pearcey JA; Joe M; Brennan PJ; Nugier-Chauvin C; Ferrières V; Lowary TL; Daniellou R; Mikušová K
Chem Biol; 2010 Dec; 17(12):1356-66. PubMed ID: 21168771
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of nonionic substrate mimics of UDP-Galp as candidate inhibitors of UDP galactopyranose mutase (UGM).
Kuppala R; Borrelli S; Slowski K; Sanders DA; Ravindranathan Kartha KP; Pinto BM
Bioorg Med Chem Lett; 2015 May; 25(9):1995-7. PubMed ID: 25819094
[TBL] [Abstract][Full Text] [Related]
11. Probing UDP-galactopyranose mutase binding pocket: a dramatic effect on substitution of the 6-position of UDP-galactofuranose.
Eppe G; Peltier P; Daniellou R; Nugier-Chauvin C; Ferrières V; Vincent SP
Bioorg Med Chem Lett; 2009 Feb; 19(3):814-6. PubMed ID: 19119008
[TBL] [Abstract][Full Text] [Related]
12. Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite.
Dykhuizen EC; Kiessling LL
Org Lett; 2009 Jan; 11(1):193-6. PubMed ID: 19067595
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and bioactivity evaluation of Galf mimics as antitubercular agents.
Liu C; Hou L; Meng A; Han G; Zhang W; Jiang S
Carbohydr Res; 2016 Jun; 429():135-42. PubMed ID: 26706033
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP.
Partha SK; van Straaten KE; Sanders DA
J Mol Biol; 2009 Dec; 394(5):864-77. PubMed ID: 19836401
[TBL] [Abstract][Full Text] [Related]
15. Synthetic UDP-galactofuranose analogs reveal critical enzyme-substrate interactions in GlfT2-catalyzed mycobacterial galactan assembly.
Poulin MB; Zhou R; Lowary TL
Org Biomol Chem; 2012 May; 10(20):4074-87. PubMed ID: 22499274
[TBL] [Abstract][Full Text] [Related]
16. Tetrafluorination of sugars as strategy for enhancing protein-carbohydrate affinity: application to UDP-Galp mutase inhibition.
N'Go I; Golten S; Ardá A; Cañada J; Jiménez-Barbero J; Linclau B; Vincent SP
Chemistry; 2014 Jan; 20(1):106-12. PubMed ID: 24311368
[TBL] [Abstract][Full Text] [Related]
17. Chemistry and biology of galactofuranose-containing polysaccharides.
Richards MR; Lowary TL
Chembiochem; 2009 Aug; 10(12):1920-38. PubMed ID: 19591187
[TBL] [Abstract][Full Text] [Related]
18. Novel UDP-glycal derivatives as transition state analogue inhibitors of UDP-GlcNAc 2-epimerase.
Stolz F; Reiner M; Blume A; Reutter W; Schmidt RR
J Org Chem; 2004 Feb; 69(3):665-79. PubMed ID: 14750790
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of Bicyclo[3.1.0]hexane-Based UDP-Galf Analogues as Inhibitors of the Mycobacterial Galactofuranosyltransferase GlfT2.
Lowary TL; Li J
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529206
[TBL] [Abstract][Full Text] [Related]
20. Methods to study the biosynthesis of bacterial furanosides.
Poulin MB; Lowary TL
Methods Enzymol; 2010; 478():389-411. PubMed ID: 20816491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
